Jump to main content
Jump to site search

Issue 6, 2016
Previous Article Next Article

Solution-phase synthesis and biological evaluation of triostin A and its analogues

Author affiliations

Abstract

Triostin A is a biosynthetic precursor of echinomycin which is one of the most potent hypoxia inducible factor 1 (HIF-1) inhibitors. An improved solution-phase synthesis of triostin A on a preparative scale has been achieved in 17.5% total yield in 13 steps. New analogues of triostin A with various aromatic chromophores, oxidized intra-peptide disulfide bridges and diastereoisomeric cyclic depsipeptide cores were also successfully synthesized. All analogues had a significant inhibitory effect on HIF-1 transcriptional activation in hypoxia and cytotoxicity on MCF-7 cells, with the exception of the derivatives containing a naphthalene chromophore or a thiosulfonate bridge. For the first time, triostin A, echinomycin and the thiosulfinate analogue of triostin A have been revealed to inhibit not only DNA binding of HIF-1 but also HIF-1α protein accumulation in MCF-7 cells. Furthermore, the thiosulfinate analogue and triostin A exhibited a hypoxia-selective cytotoxicity on MCF-7 cells. The improved solution-phase synthetic procedure described herein will contribute to the development of diverse bicyclic depsipeptide drug candidates with the potential to act as novel anti-cancer agents targeting hypoxic tumor microenvironments.

Graphical abstract: Solution-phase synthesis and biological evaluation of triostin A and its analogues

Back to tab navigation

Supplementary files

Publication details

The article was received on 08 Dec 2015, accepted on 07 Jan 2016 and first published on 07 Jan 2016


Article type: Paper
DOI: 10.1039/C5OB02505B
Author version
available:
Download author version (PDF)
Org. Biomol. Chem., 2016,14, 2090-2111

  •   Request permissions

    Solution-phase synthesis and biological evaluation of triostin A and its analogues

    K. Hattori, K. Koike, K. Okuda, T. Hirayama, M. Ebihara, M. Takenaka and H. Nagasawa, Org. Biomol. Chem., 2016, 14, 2090
    DOI: 10.1039/C5OB02505B

Search articles by author

Spotlight

Advertisements